[HTML][HTML] Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics
P Mi - Theranostics, 2020 - ncbi.nlm.nih.gov
In recent years, much progress has been motivated in stimuli-responsive nanocarriers,
which could response to the intrinsic physicochemical and pathological factors in diseased …
which could response to the intrinsic physicochemical and pathological factors in diseased …
Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation
The past few decades have witnessed an evolution of nanomedicine from biologically inert
entities to more smart systems, aimed at advancing in vivo functionality. However, we should …
entities to more smart systems, aimed at advancing in vivo functionality. However, we should …
An Adenosine Triphosphate-Responsive Autocatalytic Fenton Nanoparticle for Tumor Ablation with Self-Supplied H2O2 and Acceleration of Fe(III)/Fe(II) Conversion
L Zhang, SS Wan, CX Li, L Xu, H Cheng, XZ Zhang - Nano Letters, 2018 - ACS Publications
Chemodynamic therapy (CDT) can efficiently destroy tumor cells via Fenton reaction in the
presence of H2O2 and a robust catalyst. However, it has faced severe challenges including …
presence of H2O2 and a robust catalyst. However, it has faced severe challenges including …
ROS‐responsive polyprodrug nanoparticles for triggered drug delivery and effective cancer therapy
The application of nanoparticles (NPs) to drug delivery has led to the development of novel
nanotherapeutics for the treatment of various diseases including cancer. However, clinical …
nanotherapeutics for the treatment of various diseases including cancer. However, clinical …
Enhanced antitumor efficacy by a cascade of reactive oxygen species generation and drug release
Reactive oxygen species (ROS) can be used not only as a therapeutic agent for
chemodynamic therapy (CDT), but also as a stimulus to activate release of antitumor drugs …
chemodynamic therapy (CDT), but also as a stimulus to activate release of antitumor drugs …
Tumor‐specific drug release and reactive oxygen species generation for cancer chemo/chemodynamic combination therapy
The combination of chemotherapeutic drugs and reactive oxygen species (ROS) is a
promising strategy to achieve improved anticancer effect. Herein, a nanomedicine …
promising strategy to achieve improved anticancer effect. Herein, a nanomedicine …
[HTML][HTML] Polymeric micellar systems—a special emphasis on “smart” drug delivery
Concurrent developments in anticancer nanotechnological treatments have been observed
as the burden of cancer increases every year. The 21st century has seen a transformation in …
as the burden of cancer increases every year. The 21st century has seen a transformation in …
Controlling the biodistribution and clearance of nanomedicines
Nanomedicines improve drug bioavailability, the dose–response relationship, targeting
ability, efficacy and safety compared to conventional freely administered drugs …
ability, efficacy and safety compared to conventional freely administered drugs …
Nanoplatform-based cascade engineering for cancer therapy
J Chen, Y Zhu, C Wu, J Shi - Chemical Society Reviews, 2020 - pubs.rsc.org
Various therapeutic techniques have been studied for treating cancer precisely and
effectively, such as targeted drug delivery, phototherapy, tumor-specific catalytic therapy …
effectively, such as targeted drug delivery, phototherapy, tumor-specific catalytic therapy …
Stimulus-cleavable chemistry in the field of controlled drug delivery
Stimulus-cleavable nanoscale drug delivery systems are receiving significant attention
owing to their capability of achieving exquisite control over drug release via the exposure to …
owing to their capability of achieving exquisite control over drug release via the exposure to …